Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (review)
Irinotecan, oxaliplatin and raltitrexed for advanced colorectal cancer (review of TA33)
Summary
Irinotecan and oxaliplatin are recommended as possible treatments for people with advanced colorectal cancer, if they are used in these ways: irinotecan is given with 5-fluorouracil and folinic acid to people who have not had chemotherapy for advanced colorectal cancer before, or given on its ow ...
This guidance replaces TA33 Colorectal cancer (advanced) – irinotecan, oxaliplatin and raltitrexed.
Guidance documents
Implementing this guidance
We will consult on our review plans for this guidance in August 2008
About this guidance
Technology appraisals TA93
Issued: August 2005
